Ylermi Soini

16.4k citations

283 papers · 12.2k indexed · 1 hit paper · h-index 59

Impact in

Cancer Research top 0.5%
- Cancer-related molecular mechanisms research
Otorhinolaryngology top 0.5%
- Head and Neck Cancer Studies

Papers in

Cancer Research 73
- Cancer-related molecular mechanisms research 26
- Protease and Inhibitor Mechanisms 19
Neurology 31
- Barrier Structure and Function Studies 31

Co-authors: Paavo Pääkkö Vuokko L. Kinnula Peeter Karihtala Tuula Salo Riitta Kaarteenaho–Wiik Ibrahim O. Bello Raija Sormunen Helena Autio‐Harmainen
Journals: Apmis (15 papers)Human Pathology (15 papers)Histopathology (14 papers)Journal of Clinical Pathology (11 papers)BMC Cancer (10 papers)
Partner nations: Finland United States Sweden

In The Last Decade

Ylermi Soini

282 papers receiving 11.8k citations

Hit Papers

align trajectories log scale

Amplification of HER-2 in gastric carcinoma: association with Topoisomerase IIα gene amplification, intestinal type, poor prognosis and sensitivity to trastuzumab 2005 · 545 citations

Peers

Countries citing papers authored by Ylermi Soini

Since Specialization

Citations

This map shows the geographic impact of Ylermi Soini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ylermi Soini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ylermi Soini more than expected).

Fields of papers citing papers by Ylermi Soini

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ylermi Soini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ylermi Soini. The network helps show where Ylermi Soini may publish in the future.

Co-authors

The 25 scholars most cited alongside Ylermi Soini, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ylermi Soini Line = papers co-authored together Ylermi Soini links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	NRF2, DJ1 and SNRX1 and their prognostic impact in astrocytic gliomas. PubMed ·Joonas Haapasalo, Kristiina Nordfors, Kirsi J. Granberg, Tomi Kivioja, Matti Nykter, Hannu Haapasalo, Ylermi Soini	2018	17
2	Prognostic impact of tumour–stroma ratio in early‐stage oral tongue cancers Histopathology ·Alhadi Almangush, Ilkka Heikkinen, Nassira Bakhti, Laura K. Mäkinen, Joonas H. Kauppila, Matti Pukkila, Jaana Hagström, Jussi Laranne, Ylermi Soini, Luiz Paulo Kowalski, Reidar Grénman, Caj Haglund, Antti Mäkitie, Ricardo D. Coletta, Ilmo Leivo, Tuula Salo	2018	62
3	Vimentin–ERK Signaling Uncouples Slug Gene Regulatory Function Cancer Research ·Reetta Virtakoivu, Anja Mai, Elina Mattila, Nicola De Franceschi, Susumu Y. Imanishi, Garry L. Corthals, Riina Kaukonen, Markku Saari, Fang Cheng, Elin Torvaldson, Veli‐Matti Kosma, Arto Mannermaa, Ghaffar Muharram, Christine Gilles, John Eriksson, Ylermi Soini, James B. Lorens, Johanna Ivaska	2015	109
4	KEAP1 Genetic Polymorphisms Associate with Breast Cancer Risk and Survival Outcomes Clinical Cancer Research ·Jaana M. Hartikainen, Maria Tengström, Robert Winqvist, Arja Jukkola‐Vuorinen, Katri Pylkäs, Veli‐Matti Kosma, Ylermi Soini, (unknown)	2015	39
5	High intensity of cytoplasmic peroxiredoxin VI expression is associated with adverse outcome in diffuse large B-cell lymphoma independently of International Prognostic Index Journal of Clinical Pathology ·Milla E.L. Kuusisto, Kirsi‐Maria Haapasaari, Taina Turpeenniemi‐Hujanen, Esa Jantunen, Ylermi Soini, Pekka Peroja, Risto Bloigu, Peeter Karihtala, Outi Kuittinen	2015	7
6	SIP1 predicts progression and poor prognosis in pharyngeal squamous cell carcinoma. PubMed ·Anna Jouppila‐Mättö, Arto Mannermaa, Reijo Sironen, Veli‐Matti Kosma, Ylermi Soini, Matti Pukkila	2015	5
7	Genetic Polymorphisms and Protein Expression of NRF2 and Sulfiredoxin Predict Survival Outcomes in Breast Cancer Cancer Research ·Jaana M. Hartikainen, Maria Tengström, Veli‐Matti Kosma, Vuokko L. Kinnula, Arto Mannermaa, Ylermi Soini	2012	65
8	Low TLR9 expression defines an aggressive subtype of triple-negative breast cancer Breast Cancer Research and Treatment ·Johanna Tuomela, Jouko Sandholm, Peeter Karihtala, Joanna Ilvesaro, Katri Vuopala, Joonas H. Kauppila, Saila Kauppila, Dongquan Chen, Christine S. Pressey, Pirkko Härkönen, Kevin W. Harris, David E. Graves, Päivi Auvinen, Ylermi Soini, Arja Jukkola‐Vuorinen, Katri S. Selander	2012	58
9	Transcription factor snail1 expression and poor survival in pharyngeal squamous cell carcinoma. PubMed ·Anna Jouppila‐Mättö, Hanna Tuhkanen, Ylermi Soini, Matti Pukkila, Mervi Närkiö‐Mäkelä, Reijo Sironen, Ismo Virtanen, Arto Mannermaa, Veli‐Matti Kosma	2011	14
10	ST14 Gene Variant and Decreased Matriptase Protein Expression Predict Poor Breast Cancer Survival Cancer Epidemiology Biomarkers & Prevention ·Jaana M. Kauppinen, Veli‐Matti Kosma, Ylermi Soini, Reijo Sironen, Minna Nissinen, Timo K. Nykopp, Vesa Kärjä, Matti Eskelinen, Vesa Kataja, (unknown)	2010	30
11	Divergent Effects of Losartan and Metoprolol on Cardiac Remodeling, C‐kit⁺Cells, Proliferation and Apoptosis in the Left Ventricle after Myocardial Infarction Clinical and Translational Science ·Raisa Serpi, Anna‐Maria Tolonen, Olli Tenhunen, Oskari Pieviläinen, Anna‐Maria Kubin, Tommi Vaskivuo, Ylermi Soini, Risto Kerkelä, Hanna Leskinen, Heikki Ruskoaho	2009	14
12	Does the Oxidative Stress in Chronic Obstructive Pulmonary Disease Cause Thioredoxin/Peroxiredoxin Oxidation? Antioxidants and Redox Signaling ·Siri Lehtonen, Steffen Ohlmeier, Riitta Kaarteenaho–Wiik, Terttu Harju, Paavo Pääkkö, Ylermi Soini, Vuokko L. Kinnula	2008	23
13	Distinct Downregulation of C-Type Natriuretic Peptide System in Human Aortic Valve Stenosis Circulation ·Tuomas Peltonen, Panu Taskinen, Ylermi Soini, Jaana Rysä, Jarkko Ronkainen, Pasi Ohtonen, Jari Satta, Tatu Juvonen, Heikki Ruskoaho, Hanna Leskinen	2007	41
14	Prostatic acid phosphatase (PAP) is PI(3)P-phosphatase and its inactivation leads to change of cell polarity and invasive prostate cancer Cancer Research ·Pirkko Vihko, Ileana B. Quintero, Anna E. Rönkä, Annakaisa M. Herrala, Piritta Jäntti, Katja Porvari, Ylva Lindqvist, Helena Kaija, Anitta E. Pulkka, Jussi Vuoristo, Raija Sormunen, Ylermi Soini, Maria Halmekytö, Juhani Jänne, Toni Luokkala, Riitta Kurkela	2005	8
15	Matrix Metalloproteinases 2 and 9 and Their Tissue Inhibitors in Low Malignant Potential Ovarian Tumors Tumor Biology ·M. M auml auml tt auml, Markku Santala, Ylermi Soini, Anne Talvensaari‐Mattila, Taina Turpeenniemi‐Hujanen	2004	18
16	Laminin-5 γ2 Chain in Cryptogenic Organizing Pneumonia and Idiopathic Pulmonary Fibrosis American Journal of Respiratory and Critical Care Medicine ·Elisa Lappi‐Blanco, Riitta Kaarteenaho–Wiik, Sirpa Salo, Raija Sormunen, Marko Määttã, Helena Autio‐Harmainen, Ylermi Soini, Paavo Pääkkö	2003	27
17	Tenascin mRNA Expression at the Foci of Recent Injury in Usual Interstitial Pneumonia American Journal of Respiratory and Critical Care Medicine ·Paavo Pääkkö, Riitta Kaarteenaho–Wiik, Raimo Pöllänen, Ylermi Soini	2000	32
18	Tenascin Immunoreactivity as a Prognostic Marker in Usual Interstitial Pneumonia American Journal of Respiratory and Critical Care Medicine ·Riitta Kaarteenaho–Wiik, Taneli Tani, Raija Sormunen, Ylermi Soini, Ismo Virtanen, Paavo Pääkkö	1996	49
19	Hepatocellular carcinomas with a high proliferation index and a low degree of apoptosis and necrosis are associated with a shortened survival British Journal of Cancer ·Ylermi Soini, N Virkajärvi, V-P Lehto, Paavo Pääkkö	1996	92
20	P53 Protein Accumulation in Lung Carcinomas of Patients Exposed to Asbestos and Tobacco Smoke American Journal of Respiratory and Critical Care Medicine ·Kyösti Nuorva, Riitta Mäkitaro, E Huhti, D Kamel, Kirsi Vähäkangas, Risto Bloigu, Ylermi Soini, Paavo Pääkkö	1994	35

About Ylermi Soini

Ylermi Soini is a scholar working on Cancer Research, Neurology, Immunology and Allergy, Oncology and Otorhinolaryngology, having authored 283 papers that have together received 12.2k indexed citations. Recurring topics across this work include Glutathione Transferases and Polymorphisms (36 papers), Redox biology and oxidative stress (33 papers), Barrier Structure and Function Studies (31 papers), Cancer-related Molecular Pathways (27 papers), Cancer-related molecular mechanisms research (26 papers), Cell Adhesion Molecules Research (22 papers), Genomics, phytochemicals, and oxidative stress (21 papers) and Protease and Inhibitor Mechanisms (19 papers). The work is most often cited by research in Cancer Research (2.7k citations), Otorhinolaryngology (725 citations), Oncology (3.5k citations), Neurology (698 citations) and Molecular Biology (5.8k citations). Ylermi Soini has collaborated with scholars based in Finland, United States and Sweden. Frequent co-authors include Paavo Pääkkö, Vuokko L. Kinnula, Peeter Karihtala, Tuula Salo, Riitta Kaarteenaho–Wiik, Ibrahim O. Bello, Raija Sormunen, Helena Autio‐Harmainen, Veli‐Matti Kosma and Kirsi Vähäkangas. Their work appears in journals such as Apmis, Human Pathology, Histopathology, Journal of Clinical Pathology and BMC Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact